Cholesterol and Steroid Hormone Metabolism in Abetalipoproteinemia

  • D. Illingworth
  • N. A. Alam
  • E. E. Sundberg
Conference paper

Abstract

Phenotypic abetalipoproteinemia (ABL) may occur on the basis of two genotypically distinct disorders in which affected patients are homozygotes. The classic form of ABL is inherited as an autosomal recessive trait and obligate heterozygote parents have normal concentrations of plasma cholesterol. In contrast, homozygous hypoabetalipoprotein- emia (HHBL) is transmitted by an autosomal dominant mode of inheritance and heterozygotes have reduced levels of total and LDL cholesterol. The biochemical and clinical features of ABL and HHBL are similar and both disorders are characterised by a total absence of all apoprotein B containing lipoproteins from plasma hypocholesterolemia (plasma cholesterol 25–30 mg/dl), acanthocytes and fat malabsorption with steatorrhea. These features are present from birth whereas in untreated patients the development of progressive neurological symptoms and pigmentary retinal degeneration develop insidiously and first become clinically evident in childhood. The present report aims to briefly review three areas: 1) What is the basis for the acquired neurological changes in ABL? 2) Does an absence of plasma LDL result in increased rates of cellular cholesterol synthesis (such as occurs in vitro when cultured cells are grown in LDL depleted media)? and 3) Is steroid hormone production impaired in patients with phenotypic ABL?

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brown MS, Brannan PG, Bohmfalk HA, Brunschede GY, Dana SE, Helgeson J, Goldstein JL (1975) Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cells. J Cell Physiol 85: 425–436.PubMedCrossRefGoogle Scholar
  2. Carr BR, Simpson ER (1981a) Lipoprotein utilization and cholesterol synthesis by the human fetal adrenal gland. Endocrine Rev 2: 306–326.CrossRefGoogle Scholar
  3. Carr BR, Sadler RK, Rochelle DB, Stalmach MA, MacDonald PC, Simpson ER (1981b) Plasma lipoprotein regulation of progesterone biosynthesis by human corpus luteum tissue in organ culture. J Clin Endocrinol Metab 52: 875–881.PubMedCrossRefGoogle Scholar
  4. Ho YK, Faust JR, Bilheimer DW, Brown MS, Goldstein JL (1977) Regulation of cholesterol synthesis by low density lipoproteins in isolated human lymphocytes. J Exp Med 145: 1531–1549.PubMedCrossRefGoogle Scholar
  5. Illingworth DR, Connor WE, Lin DS, DiLiberti J (1980) Lipid metabolism in abetalipoproteinemia: a study of cholesterol absorption and sterol balance in two patients. Gastroenterology 78: 68–75.PubMedGoogle Scholar
  6. Illingworth DR, Kenny TA, Orwoll ES (1982a) Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J Clin Endocrinol Metab 54: 27–33.PubMedCrossRefGoogle Scholar
  7. Illingworth DR, Kenny T, Connor WE, Orwoll ES (1982b) Corticosteroid production in abetalipoproteinemia: evidence for an impaired response to ACTH. J Lab Clin Med (in press).Google Scholar
  8. Malloy MJ, Kane JP, Hardman DA, Hamilton RL, Dalai KB (1981) Normotri- glyceridemic abetalipoproteinemia. J Clin Invest 67: 1441–1450.PubMedCrossRefGoogle Scholar
  9. Miller RG, David CJF, Illingworth DR, Bradley W (1980) The neuropathy of abetalipoproteinemia. Neurology 30: 1286–1291.PubMedGoogle Scholar
  10. Nelson JS, Fitch CD, Fisher VW, Brown GO, Chou AC (1981) Progressive neuropathologic lesions in vitamin E deficient rhesus monkeys. J Neuropath Exp Neurol 40: 16 6–186.Google Scholar
  11. Reichl D, Myant NB, Lloyd JK (1978) Surface binding and catabolism of low density lipoprotein by circulating lymphocytes from patients with abetalipoproteinemia. Biochim Biophys Acta 530: 124–131.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • D. Illingworth
  • N. A. Alam
  • E. E. Sundberg

There are no affiliations available

Personalised recommendations